Master the "EUDAMED Hard-Gate" and address critical clinical evaluation data deficiencies with former Notified Body reviewers.

Direct insights from two former TÜV SÜD experts on how Notified Bodies evaluate clinical data under EU MDR.
Engage in three round-table discussions focused on Article 61, PMCF strategies, and SOTA clinical claims.
Dedicated 20-minute private slots with our experts to discuss your specific clinical evaluation challenges.
Tailored for Tokyo-based manufacturers with professional translators provided for seamless technical support.
Acknowledged for our excellence in real-world evidence and data architecture. This achievement underscores our commitment to streamlining regulatory success for medical device manufacturers.
Friday, April 17, 2026
12:30 ~ 17:30
JETRO Innovation Garden
Ark Mori Bldg. 7F, Tokyo
Free of Charge
Strictly Limited to 30 Seats
MDR 2026: Navigating the EUDAMED Hard-Gate requirements and the latest enforcement updates.
“Clinical Evidence - How to address the data deficiency in your clinical evaluation”
Detailed analysis of Article 61 and Equivalence/WET. Determining your PMCF strategy.
Defining measurable clinical claims and setting appropriate acceptance criteria for your CER.
Design of cost-effective PMCF surveys/studies using advanced EDC platforms.
20-minute private consultation with our experts to discuss your specific clinical questions.
JETRO Innovation Garden
ARK Mori Building 7F, Akasaka, Tokyo
Secure your seat for the Tokyo workshop and book a dedicated 1-to-1 session with our clinical & regulatory experts.
Limited to 30 seats. Register now to attend the presentations and round tables.
Optional: Reserve a private 20-minute consultation slot during the event.
Workshop concludes at 17:30
Organized by ECLEVAR MEDTECH (Global HQ: Paris, France)
Need assistance? Contact us at clientcare@eclevar.com